Monogram Orthopedics

Monogram is pleased to announce that on Monday, March 22nd, 2021, we completed our first Total Knee Arthroplasty ("TKA") procedure as a company and will now be generating revenue. Facilitating the requirements needed to perform our first case is a significant accomplishment for Monogram and the culmination of a tremendous team effort. Monogram is now: HIPAA compliant has implemented an ERP system with lot tracing has secured implant component supply has established distribution relationships has implemented several critical insurance policies has run its first cadaver lab in its Austin facility "Our philosophy has always been to build an operating business as quickly as possible, which means much more than having competitive products," said CEO Ben Sexson. "The basic infrastructure and systems required to support and scale growth in our highly regulated market are demanding and cannot be overlooked. Pulling all the pieces together to facilitate sales in such a highly regulated market is a major first step towards our goal of building a real orthopedic company. We believe the first dollars of revenue are always the hardest." Monogram has not provided sales guidance but would like the investors to calibrate expectations appropriately. "Aggressively driving sales requires a significant working capital investment, and the most compelling components of our product pipeline remain in development and our focus," said CEO Ben Sexson. "We want to build a company that can scale at the appropriate time. The goal right now is forward-thinking, and we are focused on the long-term. In the long-term, innovative products that improve patient lives are what matter to us most." Monogram expects to continue generating revenues and remains optimistic about its ongoing growth prospects.